BIORESTORATIVE THERAPIES INC (BRTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.15+2.99%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BRTX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -59.3% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 36.4% |
Growth built into the price is above our model estimate.
The price assumes 95.6 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
BRTX — CEO transition
Dated 2026-09-01
CEO — Katharyn Field: The Interim CEO and CFO stepped aside with an immediate internal successor appointed, constituting an orderly succession rather than a sudden loss of leadership.
Why it matters: Getting financing is key for the company's growth and stability. It shows investor trust.
Supportive ifA press release confirms the company has new loans or financing agreements.
Worry ifNo new financing secured. The company still relies on existing loans.
Why it matters: Stable leadership helps guide the company and builds investor trust.
Worry ifNo more executives leave in the next quarter.
Less concerning ifAnother key executive quits or is replaced in the next quarter.
Why it matters: The loan agreement is important for the company's cash flow. Good news could help operations and growth.
Supportive ifThe company gets more funding from the Revolving Loan Agreement.
Worry ifThe company has trouble getting funds from the Revolving Loan Agreement.
Why it matters: Improving revenue is key to the company's financial health. Strong growth could lead to better market perception.
Supportive ifQuarterly revenue is over $30,000, showing strong growth from past quarters.
Worry ifQuarterly revenue is under $25,000, showing no growth or a decline.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$354 on $10,000 · ±3.5% | How much price usually moves either way. |
| Bad day | $1,071 loss on $10,000 · 10.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,140 loss on $10,000 · 91.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: Securing up to $1,000,000 in loans can support operations and growth plans.
Supportive ifThe company successfully draws down at least $500,000 from the Revolving Loan Agreement.
Worry ifThe company does not use the Revolving Loan Agreement in the next quarter.
Why it matters: The delisting notice may affect the stock price and investor trust. A good outcome could stabilize the stock.
Worry ifThe company files its overdue Quarterly Report on Form 10-Q by the deadline.
Less concerning ifThe company fails to file the Form 10-Q and faces delisting.
Why it matters: Securing financing is key for the company's growth and stability. It shows investor confidence.
Supportive ifA new loan agreement is announced or financing is completed.
Worry ifNo new financing secured, leading to potential cash flow issues.
Why it matters: This split aims to raise the stock price above $1.00 for Nasdaq compliance. A successful split could stabilize investor confidence.
Supportive ifThe stock price remains above $1.00 per share for at least two consecutive trading days after the split.
Worry ifThe stock price falls below $1.00 per share within two weeks after the split.
Why it matters: Revenue growth shows how well the company is doing in the market. It shows management's skill.
Supportive ifQ3 revenue exceeds $23,170, showing continued growth from Q2.
Worry ifQ3 revenue is less than $23,170, which shows no growth or a decline.
Why it matters: Improving operating losses is important for long-term success. It shows how well costs are managed.
Supportive ifOperating losses improve. They fall below -$3.39 million in Q2.
Worry ifOperating losses worsen beyond -$3.39 million in Q2.
Why it matters: Getting funding is key for stability and growth. It shows management can support projects.
Supportive ifNew loan agreements or funding rounds over $1 million are announced.
Worry ifNo new funding announcements or signs of funding issues in the next quarter.